[1]
“Mepolizumab’s (Anti-Interleukin-5) Role in Severe Asthma: A Literature Review”, J Respirol Indones, vol. 44, no. 2, pp. 144–151, Apr. 2024, doi: 10.36497/jri.v44i2.494.